FDA panel supports approval of Glaxo lung drug Anoro

By Toni Clarke WASHINGTON (Reuters) – A federal advisory panel recommended approval of GlaxoSmithKline Plc's new drug to treat chronic obstructive pulmonary disease(COPD), but suggested the company be required to conduct further safety studies once the drug is approved. The panel of expert advisers to the U.S. Food and Drug Administration voted 11-2 on Tuesday to approve the inhaled drug, Anoro …
FDA News – Yahoo! News Search Results

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us